BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8035875)

  • 41. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.
    Walker NP; Talanian RV; Brady KD; Dang LC; Bump NJ; Ferenz CR; Franklin S; Ghayur T; Hackett MC; Hammill LD
    Cell; 1994 Jul; 78(2):343-52. PubMed ID: 8044845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrilysin-inhibitor complexes: common themes among metalloproteases.
    Browner MF; Smith WW; Castelhano AL
    Biochemistry; 1995 May; 34(20):6602-10. PubMed ID: 7756291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
    Botos I; Scapozza L; Zhang D; Liotta LA; Meyer EF
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2749-54. PubMed ID: 8610113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential processing of human ProIL-1beta by caspase-1 and subsequent folding determined by a combined in vitro and in silico approach.
    Swaan PW; Knoell DL; Helsper F; Wewers MD
    Pharm Res; 2001 Aug; 18(8):1083-90. PubMed ID: 11587477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure, function and membrane anchoring of carboxypeptidase M.
    Skidgel RA; Tan FL; Deddish PA; Li XY
    Biomed Biochim Acta; 1991; 50(4-6):815-20. PubMed ID: 1801758
    [No Abstract]   [Full Text] [Related]  

  • 46. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme.
    Ray CA; Black RA; Kronheim SR; Greenstreet TA; Sleath PR; Salvesen GS; Pickup DJ
    Cell; 1992 May; 69(4):597-604. PubMed ID: 1339309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The IL-1 beta converting enzyme as a therapeutic target.
    Miller DK; Calaycay JR; Chapman KT; Howard AD; Kostura MJ; Molineaux SM; Thornberry NA
    Ann N Y Acad Sci; 1993 Nov; 696():133-48. PubMed ID: 8109824
    [No Abstract]   [Full Text] [Related]  

  • 48. Allosteric inhibition of the neuropeptidase neurolysin.
    Hines CS; Ray K; Schmidt JJ; Xiong F; Feenstra RW; Pras-Raves M; de Moes JP; Lange JH; Melikishvili M; Fried MG; Mortenson P; Charlton M; Patel Y; Courtney SM; Kruse CG; Rodgers DW
    J Biol Chem; 2014 Dec; 289(51):35605-19. PubMed ID: 25378390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones.
    Thornberry NA; Peterson EP; Zhao JJ; Howard AD; Griffin PR; Chapman KT
    Biochemistry; 1994 Apr; 33(13):3934-40. PubMed ID: 8142397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis, structure activity relationships and crystallographic study of the ICE-inhibitor complex.
    Okamoto Y; Anan H; Nakai E; Morihira K; Yonetoku Y; Kurihara H; Sakashita H; Terai Y; Takeuchi M; Shibanuma T; Isomura Y
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):11-21. PubMed ID: 9987822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptidic p-nitroanilide substrates of interleukin-1 beta-converting enzyme.
    Reiter LA
    Int J Pept Protein Res; 1994 Jan; 43(1):87-6. PubMed ID: 8138355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme.
    Dolle RE; Hoyer D; Prasad CV; Schmidt SJ; Helaszek CT; Miller RE; Ator MA
    J Med Chem; 1994 Mar; 37(5):563-4. PubMed ID: 8126694
    [No Abstract]   [Full Text] [Related]  

  • 53. Astacin.
    Stöcker W; Zwilling R
    Methods Enzymol; 1995; 248():305-25. PubMed ID: 7674929
    [No Abstract]   [Full Text] [Related]  

  • 54. L-741,494, a fungal metabolite that is an inhibitor of interleukin-1 beta converting enzyme.
    Salvatore MJ; Hensens OD; Zink DL; Liesch J; Dufresne C; Ondeyka JG; Jürgens TM; Borris RP; Raghoobar S; McCauley E
    J Nat Prod; 1994 Jun; 57(6):755-60. PubMed ID: 7931364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Enzyme structure. "Active site"].
    Stormer FC
    Tidsskr Nor Laegeforen; 1970 Jan; 90(2):165-7. PubMed ID: 5430179
    [No Abstract]   [Full Text] [Related]  

  • 56. pH dependence studies provide insight into the structure and mechanism of thimet oligopeptidase (EC 3.4.24.15).
    Sigman JA; Edwards SR; Pabon A; Glucksman MJ; Wolfson AJ
    FEBS Lett; 2003 Jun; 545(2-3):224-8. PubMed ID: 12804780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystal structure of estrogen sulphotransferase.
    Kakuta Y; Pedersen LG; Carter CW; Negishi M; Pedersen LC
    Nat Struct Biol; 1997 Nov; 4(11):904-8. PubMed ID: 9360604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The metzincin-superfamily of zinc-peptidases.
    Bode W; Grams F; Reinemer P; Gomis-Rüth FX; Baumann U; McKay DB; Stöcker W
    Adv Exp Med Biol; 1996; 389():1-11. PubMed ID: 8860988
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of the structuro-functional organization of interleukins 1 and 2].
    Kolobov AA; Kolodkin NI; Kalinina NM; Simbirtsev AS; Ketlinskiĭ SA; Kaurov OA
    Dokl Akad Nauk SSSR; 1989; 307(3):747-51. PubMed ID: 2806071
    [No Abstract]   [Full Text] [Related]  

  • 60. The bimolecular structure of the interleukin 2 receptor.
    Smith KA
    Immunol Today; 1988 Feb; 9(2):36-7. PubMed ID: 3267167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.